# Surgical Nivolumab And Ipilimumab For Recurrent GBM

> **NCT04606316** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Patrick Wen, MD** · enrollment: 63 (actual)

## Conditions studied

- Glioblastoma
- GBM
- Glioblastoma Multiforme
- Grade IV Astrocytoma

## Interventions

- **DRUG:** Nivolumab-Placebo
- **DRUG:** Nivolumab
- **DRUG:** Ipilimumab-Placebo
- **DRUG:** Ipilimumab
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT04606316
- **Lead sponsor:** Patrick Wen, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-01
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04606316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04606316, "Surgical Nivolumab And Ipilimumab For Recurrent GBM". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04606316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*